These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 23765205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G, Cappuccio S, Casarin J, Narasimhulu DMM, Cilby WA, Glaser GE, Weaver AL, McGree ME, Keeney GL, Weroha J, Petersen IA, Mariani A.
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
    Bao L, Ding Y, Cai Q, Ning Y, Hu W, Xue X, Sun H, Hua K, Zhou X, Yi X.
    Int J Gynecol Cancer; 2016 Mar; 26(3):424-30. PubMed ID: 26825825
    [Abstract] [Full Text] [Related]

  • 8. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study.
    Kim M, Kwon BS, Chang HK, Lee S, Chang SJ, Choi JY, Park SY, Lee M, Ryu HS, Kim YB.
    J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Prognostic Factors and Adjuvant Radiotherapy on Survival in Patients with High-Grade Early-Stage Endometrial Cancer: A Retrospective Clinical Study.
    Yilmaz E, Gurocak S, Melekoglu R, Koleli I, Faydali S, Temelli O, Yar T.
    Med Sci Monit; 2019 Apr 17; 25():2811-2818. PubMed ID: 30992424
    [Abstract] [Full Text] [Related]

  • 10. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA.
    Gynecol Oncol; 2007 Nov 17; 107(2):285-91. PubMed ID: 17688923
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy.
    Foerster R, Kluck R, Rief H, Rieken S, Debus J, Lindel K.
    Radiat Oncol; 2014 Jun 18; 9():141. PubMed ID: 24941899
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
    Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S.
    Int J Gynecol Cancer; 2015 Mar 18; 25(3):431-9. PubMed ID: 25621409
    [Abstract] [Full Text] [Related]

  • 14. Survival outcomes and patterns of failure in women with stage IIIC2 endometrial carcinoma.
    Lee JK, Mahan M, Hanna RK, Elshaikh MA.
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep 18; 216():192-197. PubMed ID: 28800504
    [Abstract] [Full Text] [Related]

  • 15. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT, Rotmensch J, Yamada SD, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1272-6. PubMed ID: 12654437
    [Abstract] [Full Text] [Related]

  • 16. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
    Feng W, Hua K, Malpica A, Zhou X, Baak JP.
    Int J Gynecol Cancer; 2013 Mar 01; 23(3):488-93. PubMed ID: 23435438
    [Abstract] [Full Text] [Related]

  • 17. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A, Buscariollo D, Alban G, Buzurovic I, Cheng T, Pretz J, Krechmer B, King M, Lee L.
    Int J Gynecol Cancer; 2020 Dec 01; 30(12):1908-1914. PubMed ID: 32655012
    [Abstract] [Full Text] [Related]

  • 18. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
    Xu MJ, Chu C, Rubin S, Lin LL.
    Am J Clin Oncol; 2017 Dec 01; 40(6):598-604. PubMed ID: 26237194
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J, Wen H, Bi R, Wu X.
    J Gynecol Oncol; 2016 Mar 01; 27(2):e18. PubMed ID: 26463439
    [Abstract] [Full Text] [Related]

  • 20. Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases.
    Ozgul N, Boyraz G, Salman MC, Gultekin M, Yuce K, Ibrahimov A, Erturk A, Gungorduk K, Gulseren V, Sanci M, Turkmen O, Karalok A, Kimyon G, Turan T, Ozkan NT, Meydanli MM, Gungor T, Ayik H, Simsek T.
    Int J Gynecol Cancer; 2018 Jan 01; 28(1):161-167. PubMed ID: 28930810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.